NCT05649306 Gender Related Coping and Survivorship for Genitourinary Cancers Status RECRUITING Phase N/A
NCT05643807 Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better? Status UNKNOWN Phase NA
NCT05643690 Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay Status SUSPENDED Phase N/A
NCT05630131 ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy Status COMPLETED Phase N/A
NCT05600322 Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer Status COMPLETED Phase PHASE3
NCT05568407 A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer Status TERMINATED Phase N/A
NCT05564897 Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer Status UNKNOWN Phase PHASE2
NCT05563272 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors Status TERMINATED Phase PHASE2
NCT05562791 A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer Status RECRUITING Phase PHASE1
NCT05544552 Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05531123 Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer Status RECRUITING Phase PHASE2
NCT05524545 A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07) Status COMPLETED Phase PHASE1
NCT05520099 Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05512377 Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder Status TERMINATED Phase PHASE2
NCT05508568 A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer Status UNKNOWN Phase N/A
NCT05503563 A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder Status UNKNOWN Phase N/A
NCT05488353 A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma Status NOT_YET_RECRUITING Phase PHASE4